HomeCompareGS vs HRC

GS vs HRC: Dividend Comparison 2026

GS yields 1.92% · HRC yields 11.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GS wins by $51.52M in total portfolio value· pulled ahead in Year 7
10 years
GS
GS
● Live price
1.92%
Share price
$807.60
Annual div
$15.50
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$53.77M
Annual income
$48,880,568.44
Full GS calculator →
HRC
HRC
● Live price
11.38%
Share price
$155.96
Annual div
$17.74
5Y div CAGR
40.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.26M
Annual income
$1,423,429.65
Full HRC calculator →

Portfolio growth — GS vs HRC

📍 GS pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGSHRC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GS + HRC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GS pays
HRC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GS
Annual income on $10K today (after 15% tax)
$163.14/yr
After 10yr DRIP, annual income (after tax)
$41,548,483.17/yr
HRC
Annual income on $10K today (after 15% tax)
$966.88/yr
After 10yr DRIP, annual income (after tax)
$1,209,915.20/yr
At 15% tax rate, GS beats the other by $40,338,567.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GS + HRC for your $10,000?

GS: 50%HRC: 50%
100% HRC50/50100% GS
Portfolio after 10yr
$28.01M
Annual income
$25,151,999.04/yr
Blended yield
89.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GS right now

GS
Analyst Ratings
22
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$915.15
+13.3% upside vs current
Range: $604.00 — $1,100.00
Altman Z
0.2
Piotroski
4/9
HRC
Analyst Ratings
7
Buy
12
Hold
1
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GS buys
0
HRC buys
0
No recent congressional trades found for GS or HRC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGSHRC
Forward yield1.92%11.38%
Annual dividend / share$15.50$17.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%40.3%
Portfolio after 10y$53.77M$2.26M
Annual income after 10y$48,880,568.44$1,423,429.65
Total dividends collected$53.37M$2.14M
Payment frequencyquarterlyquarterly
SectorFinancialsStock
Analyst consensusHoldHold

Year-by-year: GS vs HRC ($10,000, DRIP)

YearGS PortfolioGS Income/yrHRC PortfolioHRC Income/yrGap
1$11,084$383.85$12,296$1,595.93$1.2KHRC
2$12,655$795.25$15,730$2,573.05$3.1KHRC
3$15,238$1,697.15$21,147$4,316.00$5.9KHRC
4$20,124$3,819.72$30,235$7,608.15$10.1KHRC
5$30,962$9,429.13$46,615$14,263.36$15.7KHRC
6$60,246$27,116.14$78,712$28,834.27$18.5KHRC
7← crossover$163,084$98,620.80$148,063$63,841.01+$15.0KGS
8$673,498$498,998.66$315,890$157,462.80+$357.6KGS
9$4,572,513$3,851,869.45$778,498$440,495.17+$3.79MGS
10$53,773,157$48,880,568.44$2,256,422$1,423,429.65+$51.52MGS

GS vs HRC: Complete Analysis 2026

GSFinancials

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through four segments: Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management. The company's Investment Banking segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and middle-market lending, relationship lending, and acquisition financing, as well as transaction banking services. This segment also offers underwriting services, such as equity underwriting for common and preferred stock and convertible and exchangeable securities; and debt underwriting for various types of debt instruments, including investment-grade and high-yield debt, bank and bridge loans, and emerging-and growth-market debt, as well as originates structured securities. Its Global Markets segment is involved in client execution activities for cash and derivative instruments; credit and interest rate products; and provision of equity intermediation and equity financing, clearing, settlement, and custody services, as well as mortgages, currencies, commodities, and equities related products. The company's Asset Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, as well as invests in corporate, real estate, and infrastructure entities. Its Consumer & Wealth Management segment offers wealth advisory and banking services, including financial planning, investment management, deposit taking, and lending; private banking; and unsecured loans, as well as accepts saving and time deposits. The company was founded in 1869 and is headquartered in New York, New York.

Full GS Calculator →

HRCStock

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Full HRC Calculator →
📬

Get this GS vs HRC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GS vs SCHDGS vs JEPIGS vs OGS vs KOGS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.